Rangering i aksjer
#15320
Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE... Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.
Pris SBS pris med markedsverdi på B
Markedsverdi av Stratec SE(SBS)
Markedsverdi: $359.75M
Per September 2026 har Stratec SE en markedsverdi på $359.75M. Dette gjør Stratec SE til det 15320th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Stratec SE fra 2000 til 2026
SBS sammenlignet med topp 5 mest populære stocks
| Pris på SBS |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.327T
|
+1,480,596.33%
|
|
|
|
|
$4.645T
|
+1,291,040.43%
|
|
|
|
|
$4.070T
|
+1,131,313.90%
|
|
|
|
|
$3.785T
|
+1,051,903.13%
|
|
|
|
|
$2.790T
|
+775,472.93%
|
